Linklaters Advises EQT Healthcare Growth on Acquisition of Europa Biosite

"Linklaters has assisted EQT Healthcare Growth in the Luxembourg corporate processes for its acquisition of Europa Biosite, a prominent distributor of life science reagents. Europa Biosite, based in Stockholm, operates in 17 countries and supports over 60,000 researchers with access to millions of scientific products. This acquisition marks EQT Healthcare Growth's third investment aimed at scaling profitable healthcare companies."

Linklaters advised EQT Healthcare Growth on the Luxembourg corporate steps related to the acquisition of Europa Biosite, a leading distributor of life science reagents. The transaction involves EQT Healthcare Growth acquiring Europa Biosite, which operates in 17 countries and supports over 60,000 researchers by providing access to more than ten million scientific products essential for life sciences research. This acquisition marks the third investment in EQT Healthcare Growth’s strategy to scale profitable healthcare companies with strong growth potential. The Linklaters team was led by Corporate Partner Rémy Bonneau and Corporate Counsel Alain Farana. They were supported by Corporate Associates Sofia Lindqvist and Alexia Hervet, as well as Investment Funds Associate Luis Gabriel Jiménez.

Linklaters Advises EQT Healthcare Growth on Acquisition of Europa Biosite

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads